WHO starts initiative for Vaccine Research that facilitates research and development (R&D) against microorganisms with significant economic burden and disease, with a particular focus on low and middle income countries. Our activities span the following areas:
In the past days, the process of vaccine development occur through a series of steps that take a long period of time or many years. Now, in given the urgent need for COVID-19 vaccines, uncommon financial investments and scientific collaborations are changing how vaccines are developed.
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia, May 2020
Temesgen Azemeraw Yitayew, Addis Ababa University, Ethiopia